Back to bills

Most Favored Patient Act of 2026HR. 7837

Last updated: 3/5/2026 · Introduced: 3/5/2026

Author: Daniel Meuser (R-PA)

TL;DR (AI)

  • This bill requires the Center for Medicare and Medicaid Innovation to test a model implementing most-favored-nation drug pricing for covered drugs.
  • Under this model, manufacturers must provide access to the second-lowest net price of a drug in a set of reference countries and report pricing information to the Secretary.
  • The model will be in effect for five years, and may be suspended if a manufacturer agrees to provide most-favored-nation pricing and increase manufacturing operations in the United States.
119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 1 more.

3 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account